Tenon Medical
Los Gatos, California, United States · Biotechnology, Healthcare, Health Care
Tenon Medical is a surgical innovation company delivering advanced solutions for chronic sacroiliac joint (SIJ) pain. Uniquely positioned in the field, Tenon offers the Catamaran™ SIJ Fusion System—a patented, minimally invasive procedure that uses a single implant to stabilize the SI joint. Backed by a seasoned team with deep expertise in surgical innovation, Tenon Medical is focused on improving
Key facts
- Headquarters
- Los Gatos, California, United States
- Employees
- 28
- Industries
- Biotechnology, Healthcare, Health Care
- Status
- Public (TNON)
- Website
- www.tenonmed.com
- Company page
Recent activity at Tenon Medical
- : TENON MEDICAL, INC. Secures Funding through Private Placement
- : Tenon Medical secures $3M in a Private Placement offering led by WallachBeth Capital. This funding will help advance their medical innovations.
- : SEC 8-K (1.01):
- : SEC 8-K (1.01):
- : SEC 8-K (8.01): Tenon Medical, Inc. announced that it fully repaid its original issue discount senior convertible promissory notes, which had an aggregate principal balance of approximately $5.16 million, ahead of their maturity date of September 11, 2026. This repayment was made on September 9, 2026, and indicates the Company's strong cash position and commitment to managing its debt effectively. The move may have positive strategic implications for Tenon Medical, as it could enhance their financial flexibility moving forward.
- : SEC 8-K (1.01): On August 27, 2026, Tenon Medical, Inc. entered into a securities purchase agreement with an institutional investor for a private placement involving the issuance of pre-funded warrants to purchase up to 597,610 shares of its common stock at a price of $5.019 per warrant, along with Series A warrants to purchase up to 1,058,517 shares of common stock. This agreement represents a significant capital raising effort for Tenon Medical, aimed at enhancing operational liquidity. The strategic implications of this private placement are substantial, allowing the company to fund further growth initiatives while providing the investor with a potentially lucrative opportunity to acquire equity at a favorable price.
- : SEC 8-K (8.01): On August 24, 2026, Tenon Medical, Inc. announced that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) following a notification from the Listing Qualifications staff of The Nasdaq Stock Market LLC. This confirms that the matter regarding compliance is now closed. The notification received and the subsequent press release indicate important regulatory compliance for the company, ensuring its continued listing on Nasdaq, which is strategic for maintaining investor confidence and market presence.
- : SEC 8-K (7.01):
- : SEC 8-K (8.01): On July 17, 2026, Tenon Medical, Inc. received a notice from Nasdaq indicating that it had regained compliance with the Stockholders’ Equity Rule. This compliance was based on the company’s earlier public offering of common stock and warrants completed on July 1, 2026, which raised $4.2 million. However, the company must further demonstrate compliance in its upcoming Quarterly Report on Form 10-Q for the period ending September 30, 2026, or face potential delisting, which could be appealed. This event is significant for maintaining the company's listing on Nasdaq and is documented in a press release issued on July 20, 2026.
- : SEC 8-K (8.01):
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
Tenon Medical funding history
| Date | Round | Amount |
|---|---|---|
| Aug 2026 | Series A | $4.3M |
| Aug 2026 | Post-IPO Equity | $3.0M |
| Mar 2026 | Venture | $4.3M |
| Nov 2025 | Funding Round | $2.9M |
| Mar 2025 | Venture | $1.5M |
Leadership
- Steven Foster, President and Chief Executive Officer
- Jim Palmer, Medical Education Manager
- Rob Harrison, Area Sales Manager, West
- Ivan Howard, Director
- Richard Ferrari, Director
- Steve Van Dick, Executive Officer
- Richard Ginn, Executive Officer
- Jeff Saterdalen, Area Sales Manager
- Kevin Williamson, Chief Financial Officer
- Wyatt Geist, Chief Innovation Officer
Verified email and direct lines for Tenon Medical’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.
Companies similar to Tenon Medical
- Procyrion · Biotechnology, Healthcare, Health Care, Manufacturing, Medical, Medical Device
- RIVANNA · Biotechnology, Healthcare, Health Care, Manufacturing, Medical, Medical Device
- SynerFuse, Inc. · Biotechnology, Healthcare, Health Care, Manufacturing, Medical, Medical Device
- Monteris Medical · Biotechnology, Healthcare, Health Care, Manufacturing, Medical, Medical Device
- Treace · Biotechnology, Healthcare, Health Care, Manufacturing, Medical, Medical Device
About Tenon Medical: questions and answers
What does Tenon Medical do?
Tenon Medical is a surgical innovation company delivering advanced solutions for chronic sacroiliac joint (SIJ) pain. Uniquely positioned in the field, Tenon offers the Catamaran™ SIJ Fusion System—a patented, minimally invasive procedure that uses a single implant to stabilize the SI joint. Backed by a seasoned team with deep expertise in surgical innovation, Tenon Medical is focused on improving
Where is Tenon Medical headquartered?
Tenon Medical is headquartered in Los Gatos, California, United States.
How many employees does Tenon Medical have?
Tenon Medical has about 28 employees.
Has Tenon Medical raised funding?
Yes. Fundz has recorded 5 funding events for Tenon Medical. The most recent, Series A of $4.3M, was in Aug 2026.
Who leads Tenon Medical?
Steven Foster is a President and Chief Executive Officer at Tenon Medical.
What is the latest news on Tenon Medical?
On Aug 31, 2026, TENON MEDICAL, INC. Secures Funding through Private Placement
Is Tenon Medical a public company?
Yes. Tenon Medical is publicly traded under the ticker TNON.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy